⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL5342826 | 0.64 | P2RY6 (0.33) | — | |
| SCHEMBL14304447 | 0.63 | CYP1A2 (0.33) | — | |
| SCHEMBL5139861 | 0.62 | MAOB (0.32) | — | |
| SCHEMBL2102618 | 0.62 | — | — | |
| SCHEMBL1533620 | 0.61 | — | — | |
| SCHEMBL19205924 | 0.59 | — | — | |
| SCHEMBL6410680 | 0.58 | KDM4E (0.32) | — | |
| SCHEMBL13138773 | 0.58 | ABCG2 (0.39) | — | |
| SCHEMBL5093557 | 0.57 | — | — | |
| SCHEMBL600651 | 0.57 | KDM4E (0.33) | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 31 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20020137794-A1 | Retinoic acid receptor (RAR) agonists, agonists for steroid/thyroid hormone receptor superfamily, and an agonist for a heterodimer partner | SALK INSTITUTE FOR BIOLOGICAL STUDIES, THE | 2002-09-26 | — | — | US | claimed |
| US-6436993-B1 | SYNERGISTIC MIXTURES OF RETINOIC ACID RECEPTOR (RAR) ANTAGONISTS AND STEROID, THYROID OR RETINOID RECEPTOR AGONISTS SUCH AS PEROXISOME PROLIFERATOR ACTIVATED RECEPTORS USED TO CONTROL CELLULAR PROCESSES | THE SALK INSTITUTE FOR BIOLOGICAL STUDIES | 2002-08-20 | — | — | US | claimed |
| WO-2001003659-A1 | USE OF RAR ANTAGONISTS AS MODULATORS OF HORMONE MEDIATED PROCESSES | THE SALK INSTITUTE FOR BIOLOGICAL STUDIES (US) | 2001-01-18 | — | — | WO | claimed |
| EP-3760193-B9 | INTRACELLULAR DELIVERY VEHICLE | KIRIN HOLDINGS KK (JP) | 2023-11-01 | — | — | EP | disclosed |
| CN-113214422-B | intracellular delivery vehicles | 麒麟控股株式会社 | 2023-10-10 | — | — | CN | disclosed |
| EP-3760193-B1 | INTRACELLULAR DELIVERY VEHICLE | KIRIN HOLDINGS KK (JP) | 2023-07-05 | — | — | EP | disclosed |
| US-11649311-B2 | Temperature-sensitive fluorescent probe for introduction into cell | KIRIN HOLDINGS KABUSHIKI KAISHA (JP) | 2023-05-16 | — | — | US | disclosed |
| US-11524947-B2 | Organic compound, light emitting diode and light emitting device having the compound | LG DISPLAY CO., LTD. (KR) | 2022-12-13 | — | — | US | disclosed |
| US-11199537-B2 | Temperature-sensitive fluorescent probe for introduction into cell | KIRIN HOLDINGS KABUSHIKI KAISHA (JP) | 2021-12-14 | — | — | US | disclosed |
| EP-3760193-A1 | INTRACELLULAR DELIVERY VEHICLE | Kirin Holdings Kabushiki Kaisha (JP) | 2021-01-06 | — | — | EP | disclosed |
| US-20200309782-A1 | INTRACELLULAR DELIVERY VEHICLE | KIRIN HOLDINGS KABUSHIKI KAISHA (JP) | 2020-10-01 | — | — | US | disclosed |
| US-20070202101-A1 | Combination therapy using anti-EGFR antibodies and anti-hormonal agents | MERCK PATENT GMBH (DE) | 2007-08-30 | — | — | US | disclosed |
| WO-2005120583-A2 | METHOD FOR PREVENTING OR TREATING CARDIAC HYPERTROPHY | WISCONSIN ALUMNI RESEARCH FOUNDATION (US) | 2005-12-22 | — | — | WO | disclosed |
| US-20050276804-A1 | Method for preventing or treating cardiac hypertrophy | WISCONSIN ALUMNI RESEARCH FOUNDATION (US) | 2005-12-15 | — | — | US | disclosed |
| US-20040131611-A1 | Combination therapy using anti-egfr antibodies and anti-hormonal agents | MERCK PATENT GMBH (DE) | 2004-07-08 | — | — | US | disclosed |
| EP-1385546-A1 | COMBINATION THERAPY USING ANTI-EGFR ANTIBODIES AND ANTI-HORMONAL AGENTS | MERCK PATENT GmbH (DE) | 2004-02-04 | — | — | EP | disclosed |
| WO-2002089842-A1 | COMBINATION THERAPY USING ANTI-EGFR ANTIBODIES AND ANTI-HORMONAL AGENTS | MERCK PATENT GMBH (DE) | 2002-11-14 | — | — | WO | disclosed |
| US-20020137794-A1 | Retinoic acid receptor (RAR) agonists, agonists for steroid/thyroid hormone receptor superfamily, and an agonist for a heterodimer partner | SALK INSTITUTE FOR BIOLOGICAL STUDIES, THE | 2002-09-26 | — | — | US | disclosed |
| US-6436993-B1 | SYNERGISTIC MIXTURES OF RETINOIC ACID RECEPTOR (RAR) ANTAGONISTS AND STEROID, THYROID OR RETINOID RECEPTOR AGONISTS SUCH AS PEROXISOME PROLIFERATOR ACTIVATED RECEPTORS USED TO CONTROL CELLULAR PROCESSES | THE SALK INSTITUTE FOR BIOLOGICAL STUDIES | 2002-08-20 | — | — | US | disclosed |
| WO-2001003659-A1 | USE OF RAR ANTAGONISTS AS MODULATORS OF HORMONE MEDIATED PROCESSES | THE SALK INSTITUTE FOR BIOLOGICAL STUDIES (US) | 2001-01-18 | — | — | WO | disclosed |